The campaign “caused Americans to lose trust in the public health system,” House Energy and Commerce Committee Chair Cathy ...

The Houston-based firm is set to scale up its Flu/Covid test manufacturing for the current respiratory virus season.

Together with Crossject's upcoming U.S. bioequivalence study, the manufactured batches and the new registration batches ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

The Near-Patient Molecular Solutions Market is estimated to register a magnificent CAGR of 8% during the forecast period.

The recall follows a warning letter sent by the US Food and Drug Administration (FDA) noting unauthorised changes to the ...

The FDA today issued a notice classifying the recall of Cue Health COVID-19 tests as Class II and revoking the tests' EUA.

The FDA found one Covid test manufacturer altered their product after they'd gained government approval. Here's what to know ...

A copy of the posters and presentation will be available on the company’s website following the conference.

“Our combo test addresses a critical gap in clinical diagnostic testing by providing a reliable and user-friendly solution for individuals to test themselves at home,” says Dr Bingliang Fang, CEO of ...

DON'T FALL FOR THESE NEW SCAMS!• FTC Blog About Latest Scams: <a href=" FDA Approved Tests: <a href=" Become a channel member ...